Manatt’s Venture Lending team represented Avenue Capital Group—an investment management firm based in New York City which makes opportunistic credit and special situations investments across the United States, Europe and Asia—in connection with the closing of its $30 million life sciences venture debt transaction for Ocugen. Ocugen is a biopharmaceutical company that develops and commercializes gene and cell therapies, vaccines and biologics. The credit facility, with a term of four years, provided $30 million, fully funded on the closing date.
The Manatt team included Partners Troy Zander, Warren Biro, Christopher M. Dayans, and Veronica Lah; Counsel Haley Fiallo; and Associates Tia Thevenin and Adriana M. Bass.